|
1
|
Dinarello CA, Novick D, Rubinstein M and
Lonnemann G: Interleukin 18 and interleukin 18 binding protein:
Possible role in immunosuppression of chronic renal failure. Blood
Purif. 21:258–270. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kim YM, Kang HS, Paik GS, Pyun GH,
Anderson KL, Torbett BE and Choi I: Roles of IFN consensus sequence
binding protein and PU.1 in regulating IL-18 gene expression. J
Immunol. 163:2000–2007. 1999.PubMed/NCBI
|
|
3
|
Muhl H, Kampfer H, Bosmann M, Frank S,
Radeke H and Pfeilschifter J: Interferon-gamma mediates gene
expression of IL-18 binding protein in nonleukocytic cells. Biochem
Biophys Res Commun. 267:960–963. 2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mazodier K, Marin V, Novick D, Farnarier
C, Robitail S, Schleinitz N, Veit V, Paul P, Rubinstein M,
Dinarello CA, et al: Severe imbalance of IL-18/IL-18BP in patients
with secondary hemophagocytic syndrome. Blood. 106:3483–3489.
2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chirathaworn C, Rianthavorn P,
Wuttirattanakowit N and Poovorawan Y: Serum IL-18 and IL-18BP
levels in patients with Chikungunya virus infection. Viral Immunol.
23:113–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Migliorini P, Anzilotti C, Pratesi F,
Quattroni P, Bargagna M, Dinarello CA and Boraschi D: Serum and
urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus
erythematosus. Eur Cytokine Netw. 21:264–271. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shan NN, Wang X, Zhu XJ, Peng J and Hou M:
Role of IL-18/IL-18BP balance in spleen of patients with primary
immune thrombocytopenia. Zhonghua Yi Xue Za Zhi. 91:239–242.
2011.PubMed/NCBI(In Chinese).
|
|
8
|
Ha CT, Li X, Fu D and Xiao M: Circulating
IL-18 Binding Protein (IL-18BP) and IL-18 as dual biomarkers of
total-body irradiation in mice. Radiat Res. 185:375–383.
2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang H, Wang J, Wang L, Xie H, Chen L and
He S: Role of IL-18 in atopic asthma is determined by balance of
IL-18/IL-18BP/IL-18R. J Cell Mol Med. 22:354–373. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mochol M, Tauboll E, Aukrust P, Ueland T,
Andreassen OA and Svalheim S: Interleukin 18 (IL-18) and its
binding protein (IL-18BP) are increased in patients with epilepsy
suggesting low-grade systemic inflammation. Seizure. 80:221–225.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yoshino O, Osuga Y, Koga K, Tsutsumi O,
Yano T, Fujii T, Kugu K, Momoeda M, Fujiwara T, Tomita K and
Taketani Y: Evidence for the expression of interleukin (IL)-18,
IL-18 receptor and IL-18 binding protein in the human endometrium.
Mol Hum Reprod. 7:649–654. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Torigoe K, Ushio S, Okura T, Kobayashi S,
Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, et
al: Purification and characterization of the human interleukin-18
receptor. J Biol Chem. 272:25737–25742. 1997.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hoshino K, Tsutsui H, Kawai T, Takeda K,
Nakanishi K, Takeda Y and Akira S: Cutting edge: generation of
IL-18 receptor-deficient mice: evidence for IL-1 receptor-related
protein as an essential IL-18 binding receptor. J Immunol.
162:5041–5044. 1999.PubMed/NCBI
|
|
14
|
Thomassen E, Bird TA, Renshaw BR, Kennedy
MK and Sims JE: Binding of interleukin-18 to the interleukin-1
receptor homologous receptor IL-1Rrp1 leads to activation of
signaling pathways similar to those used by interleukin-1. J
Interferon Cytokine Res. 18:1077–1088. 1998.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Debets R, Timans JC, Churakowa T, Zurawski
S, de Waal Malefyt R, Moore KW, Abrams JS, O'Garra A, Bazan JF and
Kastelein RA: IL-18 receptors, their role in ligand binding and
function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J
Immunol. 165:4950–4956. 2000.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shao XT, Feng L, Gu LJ, Wu LJ, Feng TT,
Yang YM, Wu NP and Yao HP: Expression of interleukin-18, IL-18BP,
and IL-18R in serum, synovial fluid, and synovial tissue in
patients with rheumatoid arthritis. Clin Exp Med. 9:215–221.
2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Corbaz A, ten Hove T, Herren S, Graber P,
Schwartsburd B, Belzer I, Harrison J, Plitz T, Kosco-Vilbois MH,
Kim SH, et al: IL-18-binding protein expression by endothelial
cells and macrophages is up-regulated during active Crohn's
disease. J Immunol. 168:3608–3616. 2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Medina L, Rabinovich A, Piura B, Dyomin V,
Levy RS and Huleihel M: Expression of IL-18, IL-18 binding protein,
and IL-18 receptor by normal and cancerous human ovarian tissues:
Possible implication of IL-18 in the pathogenesis of ovarian
carcinoma. Mediators Inflamm. 2014(914954)2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hu Y, Wang J, Zhang H, Xie H, Song W,
Jiang Q, Zhao N and He S: Enhanced Expression of IL-18 and IL-18BP
in Plasma of Patients with Eczema: Altered Expression of IL-18BP
and IL-18 receptor on mast cells. Mediators Inflamm.
2017(3090782)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wawrocki S, Kielnierowski G, Rudnicka W,
Seweryn M and Druszczynska M: Interleukin-18, Functional IL-18
Receptor and IL-18 binding protein expression in active and latent
tuberculosis. Pathogens. 9(451)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kaur D, Chachi L, Gomez E, Sylvius N and
Brightling CE: Interleukin-18, IL-18 binding protein and IL-18
receptor expression in asthma: A hypothesis showing IL-18 promotes
epithelial cell differentiation. Clin Transl Immunology.
10(e1301)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Prencipe G, Bracaglia C and De Benedetti
F: Interleukin-18 in pediatric rheumatic diseases. Curr Opin
Rheumatol. 31:421–427. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Novick D, Elbirt D, Dinarello CA,
Rubinstein M and Sthoeger ZM: Interleukin-18 binding protein in the
sera of patients with Wegener's granulomatosis. J Clin Immunol.
29:38–45. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Novick D, Schwartsburd B, Pinkus R, Suissa
D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim SH, Fantuzzi G,
et al: A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis
and extensive decrease of free IL-18. Cytokine. 14:334–342.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tschoeke SK, Oberholzer A and Moldawer LL:
Interleukin-18: A novel prognostic cytokine in bacteria-induced
sepsis. Crit Care Med. 34:1225–1233. 2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen O, Shan N, Zhu X, Wang Y, Ren P, Wei
D and Sun R: The imbalance of IL-18/IL-18BP in patients with
systemic juvenile idiopathic arthritis. Acta Biochim Biophys Sin
(Shanghai). 45:339–341. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Harel M, Girard-Guyonvarc'h C, Rodriguez
E, Palmer G and Gabay C: Production of IL-18 binding protein by
radiosensitive and radioresistant cells in CpG-Induced macrophage
activation syndrome. J Immunol. 205:1167–1175. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
McCurdy S, Yap J, Irei J, Lozano J and
Boisvert WA: IL-37-a putative therapeutic agent in cardiovascular
diseases. QJM. 115:719–725. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Belkaya S, Michailidis E, Korol CB,
Kabbani M, Cobat A, Bastard P, Lee YS, Hernandez N, Drutman S, de
Jong YP, et al: Inherited IL-18BP deficiency in human fulminant
viral hepatitis. J Exp Med. 216:1777–1790. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bufler P, Azam T, Gamboni-Robertson F,
Reznikov LL, Kumar S, Dinarello CA and Kim SH: A complex of the
IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18
activity. Proc Natl Acad Sci USA. 99:13723–13728. 2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu W, Liu G, Qin X and Wang G:
Recombinant cIL-18-binding protein as an antagonist to cIL-18
enhanced PBMCs secreting IFN-gamma. Wei Sheng Wu Xue Bao.
50:506–511. 2010.PubMed/NCBI(In Chinese).
|
|
32
|
Reznikov LL, Kim SH, Westcott JY, Frishman
J, Fantuzzi G, Novick D, Rubinstein M and Dinarello CA: IL-18
binding protein increases spontaneous and IL-1-induced
prostaglandin production via inhibition of IFN-gamma. Proc Natl
Acad Sci USA. 97:2174–2179. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Faggioni R, Cattley RC, Guo J, Flores S,
Brown H, Qi M, Yin S, Hill D, Scully S, Chen C, et al:
IL-18-binding protein protects against lipopolysaccharide-induced
lethality and prevents the development of Fas/Fas ligand-mediated
models of liver disease in mice. J Immunol. 167:5913–5920.
2001.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Plitz T, Saint-Mezard P, Satho M, Herren
S, Waltzinger C, de Carvalho Bittencourt M, Kosco-Vilbois MH and
Chvatchko Y: IL-18 binding protein protects against contact
hypersensitivity. J Immunol. 171:1164–1171. 2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lin XL, Zhu J, Wang LM, Yan F, Sha WP and
Yang HL: MiR-92b-5p inhibitor suppresses IL-18 mediated
inflammatory amplification after spinal cord injury via IL-18BP
up-regulation. Eur Rev Med Pharmacol Sci. 23:1891–1898.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yatsiv I, Morganti-Kossmann MC, Perez D,
Dinarello CA, Novick D, Rubinstein M, Otto VI, Rancan M, Kossmann
T, Redaelli CA, et al: Elevated intracranial IL-18 in humans and
mice after traumatic brain injury and evidence of neuroprotective
effects of IL-18-binding protein after experimental closed head
injury. J Cereb Blood Flow Metab. 22:971–978. 2002.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shan NN, Ji XB, Wang X, Li Y, Liu X, Zhu
XJ and Hou M: In vitro recovery of Th1/Th2 balance in PBMCs from
patients with immune thrombocytopenia through the actions of
IL-18BPa/Fc. Thromb Res. 128:e119–e124. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ushio S, Namba M, Okura T, Hattori K,
Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, et al:
Cloning of the cDNA for human IFN-gamma-inducing factor, expression
in Escherichia coli, and studies on the biologic activities of the
protein. J Immunol. 156:4274–4279. 1996.PubMed/NCBI
|
|
39
|
Alboni S, Benatti C, Montanari C, Tascedda
F and Brunello N: Chronic antidepressant treatments resulted in
altered expression of genes involved in inflammation in the rat
hypothalamus. Eur J Pharmacol. 721:158–167. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Novick D, Kim SH, Fantuzzi G, Reznikov LL,
Dinarello CA and Rubinstein M: Interleukin-18 binding protein: A
novel modulator of the Th1 cytokine response. Immunity. 10:127–136.
1999.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Dinarello CA: Novel targets for
interleukin 18 binding protein. Ann Rheum Dis. 60 (Suppl
3):iii18–iii24. 2001.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Aizawa Y, Akita K, Taniai M, Torigoe K,
Mori T, Nishida Y, Ushio S, Nukada Y, Tanimoto T, Ikegami H, et al:
Cloning and expression of interleukin-18 binding protein. FEBS
Lett. 445:338–342. 1999.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Maiti PK, Im SH, Souroujon MC and Fuchs S:
A monoclonal antibody specific for rat IL-18BP and its application
in determining serum IL-18BP. Immunol Lett. 85:65–70.
2003.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Kim SH, Eisenstein M, Reznikov L, Fantuzzi
G, Novick D, Rubinstein M and Dinarello CA: Structural requirements
of six naturally occurring isoforms of the IL-18 binding protein to
inhibit IL-18. Proc Natl Acad Sci USA. 97:1190–1195.
2000.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lee S, Kim S, Bae S, Choi J, Hong J, Ryoo
S, Jhun H, Hong K, Kim E, Jo S, et al: Development of
isoform-specific monoclonal antibodies against human IL-18 binding
protein. Hybridoma (Larchmt). 29:517–524. 2010.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Nakamura K, Asano Y, Taniguchi T,
Minatsuki S, Inaba T, Maki H, Hatano M, Yamashita T, Saigusa R,
Ichimura Y, et al: Serum levels of interleukin-18-binding protein
isoform a: Clinical association with inflammation and pulmonary
hypertension in systemic sclerosis. J Dermatol. 43:912–918.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhou J, Ling J, Wang Y, Shang J and Ping
F: Cross-talk between interferon-gamma and interleukin-18 in
melanogenesis. J Photochem Photobiol B. 163:133–143.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Iannello A, Samarani S, Allam O, Jenabian
MA, Mehraj V, Amre D, Routy JP, Tremblay C and Ahmad A: A
potentially protective role of IL-18 Binding Protein in
HIV-infected Long-Term Non-Progressors. Cytokine. 90:96–99.
2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Standing AS, Malinova D, Hong Y, Record J,
Moulding D, Blundell MP, Nowak K, Jones H, Omoyinmi E, Gilmour KC,
et al: Autoinflammatory periodic fever, immunodeficiency, and
thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene
WDR1. J Exp Med. 214:59–71. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Liuqing W, Liping X, Hui S and Jing L:
Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients
with primary Sjogren's syndrome. J Investig Med. 65:717–721.
2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Krumm B, Meng X, Xiang Y and Deng J:
Identification of small molecule inhibitors of Interleukin-18. Sci
Rep. 7(483)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Mele D, Mantovani S, Oliviero B, Grossi G,
Lombardi A, Mondelli MU and Varchetta S: Monocytes inhibit
hepatitis C virus-induced TRAIL expression on CD56bright
NK cells. J Hepatol. 67:1148–1156. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang M and Feng Z: Mechanisms of
hepatocellular injury in hepatitis A. Viruses.
13(861)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kwiatkowski K, Piotrowska A, Rojewska E,
Makuch W and Mika J: The RS504393 influences the level of
nociceptive factors and enhances opioid analgesic potency in
neuropathic rats. J Neuroimmune Pharmacol. 12:402–419.
2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yasin S, Solomon K, Canna SW,
Girard-Guyonvarc'h C, Gabay C, Schiffrin E, Sleight A, Grom AA and
Schulert GS: IL-18 as therapeutic target in a patient with
resistant systemic juvenile idiopathic arthritis and recurrent
macrophage activation syndrome. Rheumatology (Oxford). 59:442–445.
2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Gabay C, Fautrel B, Rech J, Spertini F,
Feist E, Kotter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA,
et al: Open-label, multicentre, dose-escalating phase II clinical
trial on the safety and efficacy of tadekinig alfa (IL-18BP) in
adult-onset Still's disease. Ann Rheum Dis. 77:840–847.
2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Girard-Guyonvarc'h C, Palomo J, Martin P,
Rodriguez E, Troccaz S, Palmer G and Gabay C: Unopposed IL-18
signaling leads to severe TLR9-induced macrophage activation
syndrome in mice. Blood. 131:1430–1441. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Horie K, Watanabe M, Chanbora C, Awada T,
Kunimatsu R, Uchida T, Takata T and Tanimoto K: Bovine lactoferrin
reduces extra-territorial facial allodynia/hyperalgesia following a
trigeminal nerve injury in the rat. Brain Res. 1669:89–96.
2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Italiani P, Manca ML, Angelotti F, Melillo
D, Pratesi F, Puxeddu I, Boraschi D and Migliorini P: IL-1 family
cytokines and soluble receptors in systemic lupus erythematosus.
Arthritis Res Ther. 20(27)2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
D'Angelo C, Reale M, Costantini E, Di
Nicola M, Porfilio I, de Andres C, Fernandez-Paredes L,
Sanchez-Ramon S and Pasquali L: Profiling of Canonical and
Non-Traditional Cytokine Levels in Interferon-β-Treated
relapsing-remitting-multiple sclerosis patients. Front Immunol.
9(1240)2018.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Liu C, Chen J, Liu B, Yuan S, Shou D, Wen
L, Wu X and Gong W: Role of IL-18 in transplant biology. Eur
Cytokine Netw. 29:48–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Weiss ES, Girard-Guyonvarc'h C, Holzinger
D, de Jesus AA, Tariq Z, Picarsic J, Schiffrin EJ, Foell D, Grom
AA, Ammann S, et al: Interleukin-18 diagnostically distinguishes
and pathogenically promotes human and murine macrophage activation
syndrome. Blood. 131:1442–1455. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Dong M, Zhao M, Cui M, Sun J, Meng X, Sun
W, Wang L and Du P: Interleukin-18 binding protein attenuates renal
injury of adriamycin-induced mouse nephropathy. Int J Clin Exp
Pathol. 12:3005–3012. 2019.PubMed/NCBI
|
|
64
|
Kim HS, Kim K, Lee H, Yang EA, Chun YH,
Kim HH and Kim JT: Level of interleukin-18 binding protein is
significantly different in patients with anaphylaxis than
urticaria. Asian Pac J Allergy Immunol. 40:368–373. 2022.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Zhang LM, Zhang Y, Fei C, Zhang J, Wang L,
Yi ZW and Gao G: Neutralization of IL-18 by IL-18 binding protein
ameliorates bleomycin-induced pulmonary fibrosis via inhibition of
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
508:660–666. 2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu X, Yang H, Liu Y, Jiao Y, Yang L, Wang
X, Yu W, Su D and Tian J: Remifentanil upregulates hepatic IL-18
binding protein (IL-18BP) expression through transcriptional
control. Lab Invest. 98:1588–1599. 2018.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Wang J, Long Q, Zhang W and Chen N:
Protective effects of exogenous interleukin 18-binding protein in a
rat model of acute renal ischemia-reperfusion injury. Shock.
37:333–340. 2012.PubMed/NCBI View Article : Google Scholar
|
|
68
|
O'Brien LC, Mezzaroma E, Van Tassell BW,
Marchetti C, Carbone S, Abbate A and Toldo S: Interleukin-18 as a
therapeutic target in acute myocardial infarction and heart
failure. Mol Med. 20:221–229. 2014.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Harms RZ, Creer AJ, Lorenzo-Arteaga KM,
Ostlund KR and Sarvetnick NE: Interleukin (IL)-18 binding protein
deficiency disrupts natural killer cell maturation and diminishes
circulating IL-18. Front Immunol. 8(1020)2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Zhang LM, Zhang J, Zhang Y, Wang L, Fei C,
Yi ZW and Dong L: Interleukin-18 binding protein attenuates
lipopolysaccharide-induced acute lung injury in mice via
suppression NF-κB and activation Nrf2 pathway. Biochem Biophys Res
Commun. 505:837–842. 2018.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Li YH, Wei X, Ji S, Gui SY and Zhang SM:
In vivo effects of the NLRP1/NLRP3 inflammasome pathway on latent
respiratory virus infection. Int J Mol Med. 41:3620–3628.
2018.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Doi K, Katagiri D, Negishi K, Hasegawa S,
Hamasaki Y, Fujita T, Matsubara T, Ishii T, Yahagi N, Sugaya T and
Noiri E: Mild elevation of urinary biomarkers in prerenal acute
kidney injury. Kidney Int. 82:1114–1120. 2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Li X, Cui W, Hull L, Wang L, Yu T and Xiao
M: IL-18 binding protein (IL-18BP) as a novel radiation
countermeasure after radiation exposure in mice. Sci Rep.
10(18674)2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Nakanishi Y, Horimasu Y, Yamaguchi K,
Sakamoto S, Masuda T, Nakashima T, Miyamoto S, Iwamoto H, Ohshimo
S, Fujitaka K, et al: IL-18 binding protein can be a prognostic
biomarker for idiopathic pulmonary fibrosis. PLoS One.
16(e0252594)2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Berti A, Warner R, Johnson K, Cornec D,
Schroeder D, Kabat B, Langford CA, Hoffman GS, Fervenza FC,
Kallenberg CGM, et al: Brief Report: Circulating cytokine profiles
and antineutrophil cytoplasmic antibody specificity in patients
with antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis Rheumatol. 70:1114–1121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Ter Horst R, Jaeger M, van de Wijer L, van
der Heijden WA, Janssen AMW, Smeekens SP, Brouwer MAE, van
Cranenbroek B, Aguirre-Gamboa R, Netea-Maier RT, et al: Seasonal
and nonseasonal longitudinal variation of immune function. J
Immunol. 207:696–708. 2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Min HK, Kim S, Lee JY, Kim KW, Lee SH and
Kim HR: IL-18 binding protein suppresses IL-17-induced
osteoclastogenesis and rectifies type 17 helper T cell/regulatory T
cell imbalance in rheumatoid arthritis. J Transl Med.
19(392)2021.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Otterdal K, Berg A, Michelsen AE, Yndestad
A, Patel S, Gregersen I, Halvorsen B, Ueland T, Langeland N and
Aukrust P: IL-18 and IL-18 binding protein are related to disease
severity and parasitemia during falciparum malaria. BMC Infect Dis.
21(1073)2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Haghshenas MR, Saffarian A,
Khademolhosseini A, Dehghanian A, Ghaderi A and Sotoodeh Jahromi A:
Simultaneous Increase in Serum Levels of IL-37 and IL-18 binding
protein in low-grade and high-grade brain tumors. Asian Pac J
Cancer Prev. 23:2851–2856. 2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Yang YC, Chen SN, Gan Z, Huang L, Li N,
Wang KL and Nie P: Functional characterization of IL-18 receptor
subunits, IL-18Rα and IL-18Rβ, and its natural inhibitor, IL-18
binding protein (IL-18BP) in rainbow trout Oncorhynchus mykiss. Dev
Comp Immunol. 140(104610)2023.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Zaccone P, Phillips J, Conget I, Cooke A
and Nicoletti F: IL-18 binding protein fusion construct delays the
development of diabetes in adoptive transfer and
cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol.
115:74–79. 2005.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Thompson SR, Novick D, Stock CJ, Sanders
J, Brull D, Cooper J, Woo P, Miller G, Rubinstein M and Humphries
SE: Free Interleukin (IL)-18 levels, and the impact of IL18 and
IL18BP genetic variation, in CHD patients and healthy men.
Arterioscler Thromb Vasc Biol. 27:2743–2749. 2007.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Cao Q, Cai W, Niu G, He L and Chen X:
Multimodality imaging of IL-18-binding protein-Fc therapy of
experimental lung metastasis. Clin Cancer Res. 14:6137–6145.
2008.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Kimura T, Kato Z, Ohnishi H, Tochio H,
Shirakawa M and Kondo N: Expression, purification and structural
analysis of human IL-18 binding protein: A potent therapeutic
molecule for allergy. Allergol Int. 57:367–376. 2008.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Leach ST, Messina I, Lemberg DA, Novick D,
Rubenstein M and Day AS: Local and systemic interleukin-18 and
interleukin-18-binding protein in children with inflammatory bowel
disease. Inflamm Bowel Dis. 14:68–74. 2008.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Dao T, Ohashi K, Kayano T, Kurimoto M and
Okamura H: Interferon-gamma-inducing factor, a novel cytokine,
enhances Fas ligand-mediated cytotoxicity of murine T helper 1
cells. Cell Immunol. 173:230–235. 1996.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Favilli F, Anzilotti C, Martinelli L,
Quattroni P, De Martino S, Pratesi F, Neumann D, Beermann S, Novick
D, Dinarello CA, et al: IL-18 activity in systemic lupus
erythematosus. Ann N Y Acad Sci. 1173:301–309. 2009.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Shimizu C, Fujita T, Fuke Y, Ito K,
Satomura A, Matsumoto K and Soma M: High circulating levels of
interleukin-18 binding protein indicate the severity of glomerular
involvement in systemic lupus erythematosus. Mod Rheumatol.
22:73–79. 2012.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Yamamura M, Kawashima M, Taniai M,
Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y and Makino
H: Interferon-gamma-inducing activity of interleukin-18 in the
joint with rheumatoid arthritis. Arthritis Rheum. 44:275–285.
2001.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Dinarello CA: Interleukin-18 and the
treatment of rheumatoid arthritis. Rheum Dis Clin North Am.
30:417–434, ix. 2004.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Woldbaek PR, Tonnessen T, Henriksen UL,
Florholmen G, Lunde PK, Lyberg T and Christensen G: Increased
cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial
infarction in the mouse; a potential role in cardiac dysfunction.
Cardiovasc Res. 59:122–131. 2003.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Reznikov LL, Kim SH, Zhou L, Bufler P,
Goncharov I, Tsang M and Dinarello CA: The combination of soluble
IL-18Ralpha and IL-18Rbeta chains inhibits IL-18-induced IFN-gamma.
J Interferon Cytokine Res. 22:593–601. 2002.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Meng X, Leman M and Xiang Y: Variola virus
IL-18 binding protein interacts with three human IL-18 residues
that are part of a binding site for human IL-18 receptor alpha
subunit. Virology. 358:211–220. 2007.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Krumm B, Meng X, Li Y, Xiang Y and Deng J:
Structural basis for antagonism of human interleukin 18 by poxvirus
interleukin 18-binding protein. Proc Natl Acad Sci USA.
105:20711–20715. 2008.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Palomo J, Dietrich D, Martin P, Palmer G
and Gabay C: The interleukin (IL)-1 cytokine family-Balance between
agonists and antagonists in inflammatory diseases. Cytokine.
76:25–37. 2015.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Booker CS and Grattan DR: IL1R9 Is
Evolutionarily Related to IL18BP and May Function as an IL-18
Receptor. J Immunol. 198:270–278. 2017.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Allam O, Samarani S, Jenabian MA, Routy
JP, Tremblay C, Amre D and Ahmad A: Differential synthesis and
release of IL-18 and IL-18 Binding Protein from human platelets and
their implications for HIV infection. Cytokine. 90:144–154.
2017.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Bachmann M, Pfeilschifter J and Muhl H:
Epigenetic regulation by CpG methylation splits strong from
retarded IFNү-induced IL-18BP in epithelial versus monocytic cells.
Biochim Biophys Acta Gene Regul Mech. 1861:191–199. 2018.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Wang Z, Liu Z, Wang L, Wang J, Chen L, Xie
H, Zhang H and He S: Altered expression of IL-18 binding protein
and IL-18 receptor in basophils and mast cells of asthma patients.
Scand J Immunol. 87(e12658)2018.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Gupta A, Fei YD, Kim TY, Xie A, Batai K,
Greener I, Tang H, Ciftci-Yilmaz S, Juneman E, Indik JH, et al:
IL-18 mediates sickle cell cardiomyopathy and ventricular
arrhythmias. Blood. 137:1208–1218. 2021.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Shao Q, Liu N, Li GF, Meng QC, Yao JH and
Wang N: IL-18 expression in clinical human pituitary adenoma.
Technol Health Care. 30:11–16. 2022.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Detry S, Andries J, Bloch Y, Gabay C,
Clancy DM and Savvides SN: Structural basis of human IL-18
sequestration by the decoy receptor IL-18 binding protein in
inflammation and tumor immunity. J Biol Chem.
298(101908)2022.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Yang Y, Zhang ZX, Lian D, Haig A,
Bhattacharjee RN and Jevnikar AM: IL-37 inhibits IL-18-induced
tubular epithelial cell expression of pro-inflammatory cytokines
and renal ischemia-reperfusion injury. Kidney Int. 87:396–408.
2015.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Tsuji-Takayama K, Aizawa Y, Okamoto I,
Kojima H, Koide K, Takeuchi M, Ikegami H, Ohta T and Kurimoto M:
Interleukin-18 induces interferon-gamma production through
NF-kappaB and NFAT activation in murine T helper type 1 cells. Cell
Immunol. 196:41–50. 1999.PubMed/NCBI View Article : Google Scholar
|
|
105
|
McIlroy A, Caron G, Blanchard S, Fremaux
I, Duluc D, Delneste Y, Chevailler A and Jeannin P: Histamine and
prostaglandin E up-regulate the production of Th2-attracting
chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced
CXCL10 production by immature human dendritic cells. Immunology.
117:507–516. 2006.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Walker W and Rotondo D: Prostaglandin E2
is a potent regulator of interleukin-12- and interleukin-18-induced
natural killer cell interferon-gamma synthesis. Immunology.
111:298–305. 2004.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Liao TL, Chen YM, Hsieh CW, Chen HH, Lee
HC, Hung WT, Tang KT and Chen DY: Upregulation of circulating
microRNA-134 in adult-onset Still's disease and its use as
potential biomarker. Sci Rep. 7(4214)2017.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Shi L, Zhang S, Huang Z, Hu F, Zhang T,
Wei M, Bai Q, Lu B and Ji L: Baicalin promotes liver regeneration
after acetaminophen-induced liver injury by inducing NLRP3
inflammasome activation. Free Radic Biol Med. 160:163–177.
2020.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Xiang Y and Moss B: Identification of
human and mouse homologs of the MC51L-53L-54L family of secreted
glycoproteins encoded by the Molluscum contagiosum poxvirus.
Virology. 257:297–302. 1999.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Xiang Y and Moss B: Molluscum contagiosum
virus interleukin-18 (IL-18) binding protein is secreted as a
full-length form that binds cell surface glycosaminoglycans through
the C-terminal tail and a furin-cleaved form with only the IL-18
binding domain. J Virol. 77:2623–2630. 2003.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Xiang Y and Moss B: IL-18 binding and
inhibition of interferon gamma induction by human poxvirus-encoded
proteins. Proc Natl Acad Sci USA. 96:11537–11542. 1999.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Xiang Y and Moss B: Correspondence of the
functional epitopes of poxvirus and human interleukin-18-binding
proteins. J Virol. 75:9947–9954. 2001.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Calderara S, Xiang Y and Moss B:
Orthopoxvirus IL-18 binding proteins: Affinities and antagonist
activities. Virology. 279:22–26. 2001.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Esteban DJ, Nuara AA and Buller RML:
Interleukin-18 and glycosaminoglycan binding by a protein encoded
by Variola virus. J Gen Virol. 85(Pt 5):1291–1299. 2004.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Krumm B, Meng X, Wang Z, Xiang Y and Deng
J: A unique bivalent binding and inhibition mechanism by the
yatapoxvirus interleukin 18 binding protein. PLoS Pathog.
8(e1002876)2012.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Nazarian SH, Rahman MM, Werden SJ,
Villeneuve D, Meng X, Brunetti C, Valeriano C, Wong C, Singh R,
Barrett JW, et al: Yaba monkey tumor virus encodes a functional
inhibitor of interleukin-18. J Virol. 82:522–528. 2008.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Symons JA, Adams E, Tscharke DC, Reading
PC, Waldmann H and Smith GL: The vaccinia virus C12L protein
inhibits mouse IL-18 and promotes virus virulence in the murine
intranasal model. J Gen Virol. 83(Pt 11):2833–2844. 2002.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Smith VP, Bryant NA and Alcami A:
Ectromelia, vaccinia and cowpox viruses encode secreted
interleukin-18-binding proteins. J Gen Virol. 81(Pt 5):1223–1230.
2000.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Esteban DJ and Buller RM: Identification
of residues in an orthopoxvirus interleukin-18 binding protein
involved in ligand binding and species specificity. Virology.
323:197–207. 2004.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Afonso CL, Tulman ER, Lu Z, Zsak L, Kutish
GF and Rock DL: The genome of fowlpox virus. J Virol. 74:3815–3831.
2000.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Yan Y, Deng J, Niu L, Wang Q, Yu J, Shao
H, Cao Q, Zhang Y and Tan X: Cloning and characterization of giant
panda (Ailuropoda melanoleuca) IL-18 binding protein. Res Vet Sci.
106:170–172. 2016.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Gibson MS, Steyn A, Kealy D, Kaspers B and
Fife MS: Molecular cloning and characterisation of chicken IL-18
binding protein. Dev Comp Immunol. 114(103850)2021.PubMed/NCBI View Article : Google Scholar
|
